Thomas Trimarchi
First SEC filing: July 29, 2024 · Latest: July 29, 2024
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 16, 2026 | BBIO | F | 22,781 | $79.86 | $1,819,291 | 336,529 Direct | -6.34% | Disposed | -15.8% (price as of 2026-10-02) |
| May 18, 2026 | BBIO | S 10b5-1 | 10,456 | $64.82 | $677,758 | 362,389 Direct | -2.80% | Disposed | 3.7% (price as of 2026-10-02) |
| May 18, 2026 | BBIO | S 10b5-1 | 3,195 | $65.95 | $210,710 | 359,194 Direct | -0.88% | Disposed | 2.0% (price as of 2026-10-02) |
| May 16, 2026 | BBIO | F | 22,781 | $66.13 | $1,506,508 | 372,845 Direct | -5.76% | Disposed | 1.7% (price as of 2026-10-02) |
| March 18, 2026 | BBIO | A | 59,041 | · | · | 395,626 Direct | +17.54% | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2026 | BBIO | S 10b5-1 | 13,400 | $74.71 | $1,001,114 | 336,785 Direct | -3.83% | Disposed | -10.0% (price as of 2026-10-02) |
| Feb. 17, 2026 | BBIO | S 10b5-1 | 200 | $75.38 | $15,076 | 336,585 Direct | -0.06% | Disposed | -10.8% (price as of 2026-10-02) |
| Feb. 16, 2026 | BBIO | F | 18,819 | $75.25 | $1,416,130 | 350,185 Direct | -5.10% | Disposed | -10.6% (price as of 2026-10-02) |
| Dec. 12, 2025 | BBIO | F | 13,826 | $75.15 | $1,039,024 | 369,004 Direct | -3.61% | Disposed | -10.5% (price as of 2026-10-02) |
| Nov. 17, 2025 | BBIO | S 10b5-1 | 9,978 | $66.19 | $660,444 | 389,786 Direct | -2.50% | Disposed | 1.6% (price as of 2026-10-02) |
| Nov. 17, 2025 | BBIO | S 10b5-1 | 6,956 | $66.84 | $464,939 | 382,830 Direct | -1.78% | Disposed | 0.6% (price as of 2026-10-02) |
| Nov. 16, 2025 | BBIO | F | 21,317 | $66.39 | $1,415,236 | 399,764 Direct | -5.06% | Disposed | 1.3% (price as of 2026-10-02) |
| Aug. 21, 2025 | BBIO | S | 42,237 | $49.48 | $2,089,887 | 421,081 Direct | -9.12% | Disposed | 35.9% (price as of 2026-10-02) |
| Aug. 18, 2025 | BBIO | S 10b5-1 | 1,973 | $50.94 | $100,505 | 463,318 Direct | -0.42% | Disposed | 32.0% (price as of 2026-10-02) |
| Aug. 18, 2025 | BBIO | S 10b5-1 | 15,380 | $50.14 | $771,153 | 465,291 Direct | -3.20% | Disposed | 34.1% (price as of 2026-10-02) |
| Aug. 16, 2025 | BBIO | F | 21,317 | $51.32 | $1,093,988 | 480,671 Direct | -4.25% | Disposed | 31.0% (price as of 2026-10-02) |
| May 16, 2025 | BBIO | F | 21,317 | $33.84 | $721,367 | 501,988 Direct | -4.07% | Disposed | 98.7% (price as of 2026-10-02) |
| March 19, 2025 | BBIO | A | 109,100 | · | · | 523,305 Direct | +26.34% | Acquired | (price as of 2026-10-02) |
| Feb. 16, 2025 | BBIO | F | 13,782 | $34.90 | $480,992 | 414,205 Direct | -3.22% | Disposed | 92.7% (price as of 2026-10-02) |
| Dec. 10, 2024 | BBIO | A | 50,000 | · | · | 427,987 Direct | +13.23% | Acquired | (price as of 2026-10-02) |
| Nov. 16, 2024 | BBIO | F | 17,936 | $23.72 | $425,442 | 377,987 Direct | -4.53% | Disposed | 183.5% (price as of 2026-10-02) |
| Aug. 16, 2024 | BBIO | F | 17,936 | $24.40 | $437,638 | 395,923 Direct | -4.33% | Disposed | 175.6% (price as of 2026-10-02) |
| Aug. 6, 2024 | BBIO | A | 3,160 | · | · | 3,160 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 6, 2024 | BBIO | A | 19,003 | · | · | 413,859 Direct | +4.81% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 6, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock | $24.87 | Aug. 5, 2034 | 3,160 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 29, 2024 | BBIO | Common Stock | 394,856 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy) | 115,000 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy) | 16,419 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy) | 22,145 | Direct |
| July 29, 2024 | BBIO | Stock Option (Right to Buy) | 158,127 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $675,589 | $525,000 | $4,602,488 | · | · | · | $29,293 | $5,832,369 |
| 2024 | $643,654 | $454,200 | · | · | · | · | $27,558 | $6,502,058 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.